Chargement en cours...
Multicentre cross over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer.
Trilostane and Aminoglutethimide, each given with a physiological replacement dose of hydrocortisone, were randomly allocated to 72 eligible postmenopausal advanced breast cancer patients; following treatment failure on either drug the patient continued with the other drug, if in a suitable clinical...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
1993
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1968660/ https://ncbi.nlm.nih.gov/pubmed/8260375 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|